Education
About Us
Working with TipRanks
Follow Us
IQSM - AI Analysis
Top Page
IQ Candriam ESG U.S. Mid Cap Equity ETF (IQSM)
Rating:69Neutral
Price Target:
$37.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Insmed and Credo Technology, have delivered strong year-to-date performance, supporting overall returns.
Low Expense Ratio
The ETF has a very low expense ratio compared to industry averages, helping investors keep more of their returns.
Sector Diversification
The fund is spread across multiple sectors, including Industrials, Technology, and Health Care, reducing reliance on any single industry.
Negative Factors
High Geographic Concentration
The ETF is heavily concentrated in U.S. companies, offering little exposure to international markets.
Mixed Performance in Top Holdings
Some top holdings, such as United Therapeutics and Nutanix, have lagged in year-to-date performance, which could weigh on future returns.
Small Exposure to Defensive Sectors
The ETF has limited allocation to defensive sectors like Utilities and Consumer Defensive, which may increase vulnerability during market downturns.
IQSM vs. SPDR S&P 500 ETF (SPY)
AUM212.15M
RegionNorth America
Expense Ratio0.15%
Beta0.95
IssuerNew York Life Investments
Inception DateOct 25, 2022
Dividend YieldN/A
Asset ClassEquity
Index TrackedNYLI Candriam U.S. Mid Cap Equity Index - Benchmark TR Net
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,124
30 Day Avg. Volume5,375
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.72Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering228
IQSM Summary
The IQ Candriam ESG U.S. Mid Cap Equity ETF (Ticker: IQSM) is an investment fund that focuses on mid-sized U.S. companies while prioritizing sustainability through environmental, social, and governance (ESG) criteria. It includes companies like Insmed and Comfort Systems, offering exposure to industries such as technology, healthcare, and industrials. This ETF is ideal for investors seeking growth potential and ethical investing, as mid-cap stocks often balance stability and growth. However, new investors should be aware that the ETF’s performance can fluctuate with the overall market, and mid-cap stocks may be more volatile than large-cap stocks.
How much will it cost me?The IQ Candriam ESG U.S. Mid Cap Equity ETF (Ticker: IQSM) has an expense ratio of 0.15%. This means you’ll pay $1.50 per year for every $1,000 invested. This expense ratio is lower than average because the fund is passively managed, tracking an index rather than relying on active management.
What would affect this ETF?The IQ Candriam ESG U.S. Mid Cap Equity ETF could benefit from growing interest in sustainable investing and the strong performance of mid-cap companies, particularly in sectors like technology and healthcare, which are well-represented in its holdings. However, potential risks include economic slowdowns or rising interest rates, which could negatively impact mid-cap stocks and sectors like consumer cyclical and real estate. Regulatory changes affecting ESG criteria or specific industries could also influence the ETF's future performance.
IQSM Top 10 Holdings
The IQ Candriam ESG U.S. Mid Cap Equity ETF leans heavily into industrials and technology, sectors that make up nearly 40% of its portfolio, signaling a focus on innovation and infrastructure. Ciena is rising steadily, buoyed by strong financial performance and bullish sentiment, while Insmed’s clinical successes are driving momentum despite financial hurdles. On the flip side, Nutanix and F5 Networks are lagging, with bearish trends and valuation concerns holding them back. With its U.S.-centric exposure and ESG focus, the fund offers a balanced yet dynamic approach to mid-cap investing.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Insmed | 1.66% | $3.52M | $39.72B | 173.50% | 53 Neutral | |
| Comfort Systems | 1.57% | $3.33M | $34.48B | 150.44% | 80 Outperform | |
| Credo Technology Group Holding Ltd | 1.27% | $2.68M | $31.25B | 350.81% | 75 Outperform | |
| Ciena | 1.24% | $2.64M | $26.74B | 199.75% | 70 Outperform | |
| Tapestry | 1.07% | $2.26M | $22.01B | 118.97% | 64 Neutral | |
| Twilio | 0.91% | $1.93M | $20.63B | 55.54% | 71 Outperform | |
| nVent Electric | 0.87% | $1.85M | $18.13B | 63.34% | 79 Outperform | |
| Guidewire | 0.86% | $1.83M | $19.27B | 22.89% | 69 Neutral | |
| United Therapeutics | 0.86% | $1.83M | $18.89B | 16.42% | 79 Outperform | |
| CH Robinson | 0.85% | $1.79M | $17.97B | 48.22% | 71 Outperform |
IQSM Technical Analysis
Neutral
―
Price Trends
34.03
Negative
33.31
Positive
32.25
Positive
Market Momentum
0.04
Positive
49.02
Neutral
15.19
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQSM, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 33.97, equal to the 50-day MA of 34.03, and equal to the 200-day MA of 32.25, indicating a neutral trend. The MACD of 0.04 indicates Positive momentum. The RSI at 49.02 is Neutral, neither overbought nor oversold. The STOCH value of 15.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IQSM.
IQSM Peer Comparison
Comparison Results
Performance Comparison
IQSM
IQ Candriam ESG U.S. Mid Cap Equity ETF
33.94
1.53
4.72%
EZM
WisdomTree U.S. MidCap Fund
―
―
―
XMLV
Invesco S&P MidCap Low Volatility ETF
―
―
―
BKMC
BNY Mellon US Mid Cap Core Equity ETF
―
―
―
GRPM
Invesco S&P MidCap 400 GARP ETF
―
―
―
PTMC
Pacer Trendpilot US Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents